Press-release: A new reagent kit for the diagnosis of coronavirus COVID-19
«LYTECH» Co. Ltd. offers a new highly sensitive reagent kit of our own production POLYVIR SARS-CoV-2 for the diagnosis of coronavirus infection COVID-19.
The reagent kit POLYVIR SARS-CoV-2 (certificate of registration No. RZN 2020/9904 from the 27.03.2020) is based on the detection of SARS-CoV-2 coronavirus RNA by reverse transcription polymerase chain reaction (PCR) and is available in two versions: BASE and EXPRESS:
1. The BASE version contains reagents intended for PCR analysis. The full cycle of the study of the sample with sorbent isolation takes 3 hours.
2. The EXPRESS version is supplemented with a reagent kit designed for express isolation of RNA from clinical material. It allows you to reduce the entire cycle of the sample study, including sample preparation and PCR analysis, up to 2 hours.
Rapid RNA extraction takes only 15 minutes and is characterized by the simplicity and convenience of the procedure for extracting RNA from nasal, nasopharyngeal and/or oropharyngeal swabs. It is also possible to use other types of biomaterial. In these cases, for optimal results, the manufacturer recommends using the RNA isolation set "NA-sorbent " (certificate of registration No. RZN 2019/9331) together with the BASE version of the POLYVIR SARS-CoV-2 kit.
To work with the reagent kit POLYVIR SARS-CoV-2, a minimum amount of consumables is required. The necessary plastic for working with clinical samples is already included in the EXPRESS package.
With the reagent kit POLYVIR SARS-CoV-2, up to 103 genome equivalents/ml of coronavirus can be detected in an RNA sample isolated from a clinical sample. Due to insufficient knowledge of the genetic diversity of the virus, the reagent kit POLYVIR SARS-CoV-2 provides for the control of SARS-CoV-2 coronavirus mutations to reduce the risk of false negative results.
The reagent kit POLYVIR SARS-CoV-2 is adapted to work on the most popular models of real-time amplifiers.